Total Payments
$15,595
2024 Payments
$5,131
Companies
35
Transactions
768
Medicare Patients
1,362
Medicare Billing
$111,878
Payment Breakdown by Category
Food & Beverage$15,272 (97.9%)
Education$322.29 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,272 | 758 | 97.9% |
| Education | $322.29 | 10 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,304 | 152 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,481 | 106 | $0 (2024) |
| Janssen Biotech, Inc. | $1,479 | 56 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,442 | 75 | $0 (2024) |
| PFIZER INC. | $901.95 | 74 | $0 (2024) |
| Celgene Corporation | $791.03 | 72 | $0 (2024) |
| QOL Medical, LLC | $669.59 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $568.22 | 36 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $481.81 | 23 | $0 (2024) |
| Lilly USA, LLC | $435.94 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,131 | 213 | ABBVIE INC. ($942.61) |
| 2023 | $4,665 | 232 | ABBVIE INC. ($989.31) |
| 2022 | $3,015 | 177 | ABBVIE INC. ($570.16) |
| 2021 | $2,784 | 146 | AbbVie Inc. ($802.23) |
All Payment Transactions
768 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.11 | General |
| Category: Immunology | ||||||
| 12/04/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $43.06 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $93.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 347 | 414 | $118,795 | $30,540 |
| 2022 | 5 | 310 | 382 | $112,188 | $28,945 |
| 2021 | 6 | 368 | 400 | $103,267 | $27,637 |
| 2020 | 4 | 337 | 389 | $119,278 | $24,756 |
Total Patients
1,362
Total Services
1,585
Medicare Billing
$111,878
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 270 | $73,980 | $19,434 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $27,192 | $6,451 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 43 | $7,998 | $2,186 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,500 | $1,352 | 24.6% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 15 | 15 | $4,125 | $1,117 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 258 | $70,692 | $19,307 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $28,428 | $6,966 | 24.5% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 23 | 25 | $6,420 | $1,731 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $3,348 | $491.64 | 14.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,300 | $449.67 | 13.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 159 | $43,566 | $11,324 | 26.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 118 | $21,948 | $6,613 | 30.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 31 | $11,315 | $3,592 | 31.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 58 | 58 | $15,950 | $3,442 | 21.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $7,416 | $1,927 | 26.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 16 | 16 | $3,072 | $738.90 | 24.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 210 | 260 | $71,240 | $17,117 | 24.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 82 | 82 | $22,550 | $4,555 | 20.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 13 | 13 | $19,164 | $1,542 | 8.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 34 | $6,324 | $1,541 | 24.4% |
About Narin Tipton, CNP
Narin Tipton, CNP is a Family healthcare provider based in Lees Summit, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1477720654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Narin Tipton, CNP has received a total of $15,595 in payments from pharmaceutical and medical device companies, with $5,131 received in 2024. These payments were reported across 768 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($15,272).
As a Medicare-enrolled provider, Tipton has provided services to 1,362 Medicare beneficiaries, totaling 1,585 services with total Medicare billing of $111,878. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Lees Summit, MO
- Active Since 05/15/2008
- Last Updated 01/06/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1477720654
Products in Payments
- XIFAXAN (Drug) $1,880
- STELARA (Biological) $1,192
- ENTYVIO (Biological) $1,115
- ZEPOSIA (Drug) $1,050
- RINVOQ (Biological) $905.48
- XELJANZ (Drug) $849.72
- SKYRIZI (Biological) $842.49
- DIFICID (Drug) $568.22
- DUPIXENT (Biological) $517.35
- OCALIVA (Drug) $481.81
- SUCRAID (Drug) $468.89
- TRULANCE (Drug) $454.95
- INJECTAFER (Drug) $424.68
- OMVOH (Drug) $420.95
- HUMIRA (Biological) $415.31
- IBSRELA (Drug) $342.72
- CREON (Drug) $276.34
- ZENPEP (Drug) $253.10
- REMICADE (Biological) $227.13
- Sucraid (Drug) $200.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lees Summit
Tamera Wolf, Fnp, FNP
Family — Payments: $144,477
Family $144,477
Crystal Davison, Aprn, APRN
Family — Payments: $10,819
Family $10,819
Christine Hunt
Family — Payments: $9,165
Family $9,165
Stephanie Justin, Cnp, CNP
Family — Payments: $7,270
Family $7,270
Rachel Walter, Np-C, NP-C
Family — Payments: $7,257
Family $7,257
Dawn Childs, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $7,254
Family $7,254